Muhaqiqeen ne khoon mein ek aisa molecular signal daryaft kiya hai jo ovary cancer banne se pehle ki khurdbeeni tabdeeliyon ki nishandahi karta hai. Yeh ek aisi beemari ki jald tashkhees ki janib mumkina pesh raft hai jo aksar phail jane ke baad hi pakri jati hai.
Yeh tehqeeq Mangal ko tibbi jareeday Nature Medicine mein shaya hui. Is ki qiyadat California ke Newport Beach mein Hoag Family Cancer Institute ke Rajan Gogna ne ki.
Ovary cancer aksar fallopian tubes ki androoni teh mein khurdbeeni tabdeeliyon se shuru hota hai. Cancer se pehle ki in tabdeeliyon ko serous tubal intraepithelial carcinoma, yani STIC, kaha jata hai.
Tehqeeq mein maloom hua ke is kefiyat mein mubtala khawateen ke khoon mein Tu-Stroma naami ek RNA molecule ki satah zyada hoti hai. Khoon mein is ki paimaish se mutasira khawateen mein se 92.3 fisad mein STIC ki nishandahi hui, jabke 98.2 fisad sehatmand khawateen ko durust taur par sehatmand qarar diya gaya.
Muhaqiqeen ke mutabiq jin khawateen ko ovary cancer ka moroosi khatra ho, un mein taqriban 72 fisad musbat nataij durust hon ge, jabke manfi nataij taqriban hamesha durust hon ge.
Gogna ne ek bayan mein kaha, “Hum ne ek bunyadi taur par mukhtalif sawal poocha: agar hum hamla awar cancer banne se pehle hi ibtidai molecular intebahi alamaat pehchan saken to kya hoga?”
Zyada khatre wali bohat si khawateen ko fallopian tubes aur ovaries nikalwane ki ehtiyati surgery ke mushkil faislon ka samna hota hai. Tehqeeq ki shareek musannifa Dr Esha Madan ne kaha ke aaj yeh faisle zyada tar moroosi khatre ki bunyad par hote hain, yeh jane baghair ke cancer se pehle ki tabdeeliyan waqai maujood hain ya nahin.
Yeh test abhi tehqeeqi marhale mein hai. Muhaqiqeen ne yeh nahin bataya ke yeh kab ya kaise aam istemal ke liye dastiyab hoga.
